Table 2 Surgery and planned breast cancer treatment
| Â | Number (%) |
|---|---|
Surgery type | Â |
  Mastectomy | 15 (3%) |
  Mastectomy + sentinel node biopsy | 69 (13%) |
  Mastectomy + axillary clearance | 95 (18%) |
  Wide local excision (WLE) | 63 (12%) |
  WLE + sentinel node biopsy | 230 (43%) |
  WLE + axillary clearance | 68 (13%) |
Planned cancer treatment | Â |
  No further systemic treatment | 82 (16%) |
  Aromatase inhibitor only | 95 (18%) |
  Tamoxifen only | 117 (22%) |
  Chemotherapy only | 72 (14%) |
of which taxane chemotherapy – 37 (51%) | |
Aromatase inhibitor + chemotherapy | 52 (10%) |
of which taxane chemotherapy – 16 (31%) | |
Tamoxifen + chemotherapy | 107 (20%) |
of which taxane chemotherapy – 51 (48%) | |